Table III.
Correlations between clinical and laboratory parameters. All participants are included (n = 38)
| Parameter | Symptoms/medication score during the season [points] |
Change from baseline | |||
|---|---|---|---|---|---|
| FEV1 (%) | FEV1%FVC (%) | FENO [ppb] | |||
| Baseline value: | |||||
| IL-10 [pg/ml] | R | –0.08 | –0.07 | 0.07 | –0.13 |
| p | 0.6283 | 0.6929 | 0.6823 | 0.4279 | |
| TGF-β [pg/ml] | R | 0.09 | 0.09 | 0.07 | 0.09 |
| p | 0.6002 | 0.5827 | 0.6905 | 0.5723 | |
| CD4+CD25+Foxp3+[%] | R | 0.15 | 0.00 | 0.00 | –0.10 |
| p | 0.3573 | 0.9943 | 0.9938 | 0.5546 | |
| Vitamin D [ng/ml] | R | 0.13 | –0.11 | 0.06 | –0.12 |
| p | 0.4369 | 0.5177 | 0.7013 | 0.4619 | |
| Change from baseline: | |||||
| CD4+CD25+Foxp3+[%] | R | –0.23 | –0.09 | 0.02 | –0.37 |
| p | 0.1663 | 0.5768 | 0.8836 | 0.0217 | |
| Vitamin D [ng/ml] | R | –0.18 | 0.06 | –0.13 | –0.06 |
| p | 0.2787 | 0.7255 | 0.4465 | 0.7086 | |
R – Spearman correlation coefficient, p – p-value.